Loading...

Robert E Reiter

Title(s)Professor, Urology
SchoolMedicine
Address924 Westwood Boulevard 1000
Los Angeles CA 90024
Phone47224
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Multifunctional immunoPET tracers for pancreatic and prostate cancer
    NIH/NCI R01CA174294Apr 1, 2013 - Mar 31, 2016
    Role: Co-Principal Investigator
    UCLA SPORE in Prostate Cancer
    NIH/NCI P50CA092131Jul 1, 2001 - Jun 30, 2013
    Role: Principal Investigator
    MARKERS OF ANDROGEN INDEPENDENT PROSTATE CANCER
    NIH/NCI K08CA074169Jul 29, 1997 - Jun 30, 2002
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Eur J Nucl Med Mol Imaging. 2020 Aug 17. Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin J, Hope TA. PMID: 32808077.
      View in: PubMed   Mentions:    Fields:    
    2. The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells. Prostate Cancer Prostatic Dis. 2020 Jul 09. Nickols NG, Ganapathy E, Nguyen C, Kane N, Lin L, Diaz-Perez S, Nazarian R, Mathis C, Felix C, Basehart V, Zomorodian N, Kwak J, Kishan AU, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Chu FI, Romero T, Elashoff D, Reiter RE, Schaue D. PMID: 32647353.
      View in: PubMed   Mentions:    Fields:    
    3. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2. Abdom Radiol (NY). 2020 Jul; 45(7):2225-2234. Afshari Mirak S, Mohammadian Bajgiran A, Sung K, Asvadi NH, Markovic D, Felker ER, Lu D, Sisk A, Reiter RE, Raman SS. PMID: 31549211.
      View in: PubMed   Mentions:    Fields:    
    4. Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology. Radiology. 2020 Aug; 296(2):348-355. Zhang Z, Wu HH, Priester A, Magyar C, Afshari Mirak S, Shakeri S, Mohammadian Bajgiran A, Hosseiny M, Azadikhah A, Sung K, Reiter RE, Sisk AE, Raman S, Enzmann DR. PMID: 32515678.
      View in: PubMed   Mentions:    Fields:    
    5. Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer. Eur Urol. 2020 Sep; 78(3):327-332. Kishan AU, Romero T, Alshalalfa M, Liu Y, Tran PT, Nickols NG, Ye H, Sajed D, Rettig MB, Reiter RE, Garraway IP, Spratt DE, Freedland SJ, Zhao X, Li Z, Deek M, Livingstone J, Mahal BA, Nguyen PL, Feng FY, Den RB, Schaeffer EM, Lotan TL, Karnes RJ, Klein EA, Ross AE, Grogan T, Davicioni E, Elashoff D, Boutros PC, Weidhaas JB. PMID: 32461072.
      View in: PubMed   Mentions:    Fields:    
    6. [89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model. Mol Imaging Biol. 2020 04; 22(2):367-376. Zettlitz KA, Tsai WK, Knowles SM, Salazar FB, Kobayashi N, Reiter RE, Wu AM. PMID: 31209779.
      View in: PubMed   Mentions:    Fields:    
    7. Caught Between a Rock and a Hard Place. Int J Radiat Oncol Biol Phys. 2020 Mar 12. Kishan AU, Reiter RE. PMID: 32173187.
      View in: PubMed   Mentions:    Fields:    
    8. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. Eur Urol. 2020 02; 77(2):201-208. Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY, Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC, Elashoff D, Collette L, Sandler HM. PMID: 31718822.
      View in: PubMed   Mentions: 3     Fields:    
    9. Efficacy of a preprostatectomy multi-modal penile rehabilitation regimen on recovery of postoperative erectile function. Int J Impot Res. 2020 May; 32(3):323-328. Osadchiy V, Eleswarapu SV, Mills SA, Pollard ME, Reiter RE, Mills JN. PMID: 31474755.
      View in: PubMed   Mentions:    Fields:    
    10. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019 09; 20(9):1286-1294. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. PMID: 31375469.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    11. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI. AJR Am J Roentgenol. 2019 09; 213(3):W134-W142. Bajgiran AM, Mirak SA, Sung K, Sisk AE, Reiter RE, Raman SS. PMID: 31216201.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Focal Therapy Should Not Be Considered for Men with Gleason Grade Group 3-5 Prostate Cancer. Eur Urol Focus. 2020 03 15; 6(2):203-204. Johnson DC, Reiter RE. PMID: 31202786.
      View in: PubMed   Mentions:    Fields:    
    13. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. Eur Urol. 2020 01; 77(1):3-10. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 30992160.
      View in: PubMed   Mentions: 1     Fields:    
    14. Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADS™ version 2 Category and Staging with Whole Mount Histopathology Correlation. J Urol. 2019 03; 201(3):496-502. Mirak SA, Shakeri S, Bajgiran AM, Felker ER, Sung KH, Asvadi NH, Khoshnoodi P, Markovic D, Ponzini D, Ahuja P, Sisk A, Reiter RE, Lu D, Raman SS. PMID: 30273608.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Cancer core length from targeted biopsy: an index of prostate cancer volume and pathological stage. BJU Int. 2019 08; 124(2):275-281. Simopoulos DN, Sisk AE, Priester A, Felker ER, Kwan L, Delfin MK, Reiter RE, Marks LS. PMID: 30694605.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. Eur Urol Oncol. 2019 Feb 01. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. PMID: 31411981.
      View in: PubMed   Mentions:    Fields:    
    17. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy. J Urol. 2019 01; 201(1):91-97. Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE. PMID: 30142318.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy. J Urol. 2019 01; 201(1):91-97. Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE. PMID: 30577397.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Adjusting Our Approach to Multiparametric Magnetic Resonance Imaging-based Targeted Prostate Biopsies: Considerations After the FUTURE Trial. Eur Urol. 2019 04; 75(4):591-592. Sadun TY, Reiter RE. PMID: 30591355.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. Eur Urol. 2019 05; 75(5):712-720. Johnson DC, Raman SS, Mirak SA, Kwan L, Bajgiran AM, Hsu W, Maehara CK, Ahuja P, Faiena I, Pooli A, Salmasi A, Sisk A, Felker ER, Lu DSK, Reiter RE. PMID: 30509763.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    21. 3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard. Abdom Radiol (NY). 2018 11; 43(11):3117-3124. Asvadi NH, Afshari Mirak S, Mohammadian Bajgiran A, Khoshnoodi P, Wibulpolprasert P, Margolis D, Sisk A, Reiter RE, Raman SS. PMID: 29725743.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer. EJNMMI Res. 2018 Oct 29; 8(1):96. Lückerath K, Wei L, Fendler WP, Evans-Axelsson S, Stuparu AD, Slavik R, Mona CE, Calais J, Rettig M, Reiter RE, Herrmann K, Radu CG, Czernin J, Eiber M. PMID: 30374743.
      View in: PubMed   Mentions:
    23. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models. Clin Cancer Res. 2019 01 01; 25(1):188-200. Zhang M, Kobayashi N, Zettlitz KA, Kono EA, Yamashiro JM, Tsai WK, Jiang ZK, Tran CP, Wang C, Guan J, Wu AM, Reiter RE. PMID: 30301826.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    24. Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT. Clin Genitourin Cancer. 2019 02; 17(1):e53-e55. Polverari G, Ceci F, Allen-Auerbach M, Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM, Czernin J, Calais J. PMID: 30293922.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate. Abdom Radiol (NY). 2018 09; 43(9):2487-2496. Nagarajan MB, Raman SS, Lo P, Lin WC, Khoshnoodi P, Sayre JW, Ramakrishna B, Ahuja P, Huang J, Margolis DJA, Lu DSK, Reiter RE, Goldin JG, Brown MS, Enzmann DR. PMID: 29460041.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center. Urol Oncol. 2018 09; 36(9):401.e19-401.e25. Salmasi A, Faiena I, Wu J, Sisk AE, Sachveda A, Vandel JJ, Chamie K, Marks LS, Reiter RE. PMID: 30064933.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer. J Nucl Med. 2018 09; 59(9):1392-1397. Lückerath K, Stuparu AD, Wei L, Kim W, Radu CG, Mona CE, Calais J, Rettig M, Reiter RE, Czernin J, Slavik R, Herrmann K, Eiber M, Fendler WP. PMID: 29602819.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    28. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy. J Urol. 2018 09; 200(3):564-572. Salmasi A, Said J, Shindel AW, Khoshnoodi P, Felker ER, Sisk AE, Grogan T, McCullough D, Bennett J, Bailey H, Lawrence HJ, Elashoff DA, Marks LS, Raman SS, Febbo PG, Reiter RE. PMID: 29524506.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Anatomic and Molecular Imaging in Prostate Cancer. Cold Spring Harb Perspect Med. 2018 03 01; 8(3). Miller ET, Salmasi A, Reiter RE. PMID: 28710256.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. J Natl Cancer Inst. 2017 Dec 01; 109(12). Wyatt AW, Annala M, Aggarwal R, Beja K, Feng F, Youngren J, Foye A, Lloyd P, Nykter M, Beer TM, Alumkal JJ, Thomas GV, Reiter RE, Rettig MB, Evans CP, Gao AC, Chi KN, Small EJ, Gleave ME. PMID: 29206995.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    31. Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study. JCO Clin Cancer Inform. 2017 11; 1:1-6. Kishan AU, Cheng EM, Schmidt E, Saigal C, Reiter RE, Kupelian PA, Steinberg ML, King CR. PMID: 30657383.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer. J Nucl Med. 2018 02; 59(2):177-182. Donin NM, Reiter RE. PMID: 28986509.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy. J Urol. 2018 02; 199(2):453-458. Nassiri N, Chang E, Lieu P, Priester AM, Margolis DJA, Huang J, Reiter RE, Dorey FJ, Marks LS, Natarajan S. PMID: 28830754.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    34. Multi-parametric magnetic resonance imaging as a management decision tool. Transl Androl Urol. 2017 Jun; 6(3):472-482. Johnson DC, Reiter RE. PMID: 28725589.
      View in: PubMed   Mentions:
    35. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer. Urology. 2017 Sep; 107:171-177. Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU. PMID: 28552819.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma. Radiology. 2017 07; 284(1):109-119. Jamshidi N, Margolis DJ, Raman S, Huang J, Reiter RE, Kuo MD. PMID: 28453432.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2016 10 18; 113(42):E6457-E6466. Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON. PMID: 27694579.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    38. Risk stratification of prostate cancer 2016. Scand J Clin Lab Invest Suppl. 2016; 245:S54-9. Reiter RE. PMID: 27533326.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    39. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 05; 71(5):766-773. Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. PMID: 27452951.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    40. Is Targeted Biopsy Applicable to Patients on Active Surveillance? Eur Urol. 2017 02; 71(2):181-182. Prado K, Reiter RE. PMID: 27292867.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies. Cancer. 2016 Mar 15; 122(6):884-92. Filson CP, Natarajan S, Margolis DJ, Huang J, Lieu P, Dorey FJ, Reiter RE, Marks LS. PMID: 26749141.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    42. Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time. Clin Cancer Res. 2016 Mar 15; 22(6):1403-12. Sonn GA, Behesnilian AS, Jiang ZK, Zettlitz KA, Lepin EJ, Bentolila LA, Knowles SM, Lawrence D, Wu AM, Reiter RE. PMID: 26490315.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    43. Accelerated echo planar J-resolved spectroscopic imaging in prostate cancer: a pilot validation of non-linear reconstruction using total variation and maximum entropy. NMR Biomed. 2015 Nov; 28(11):1366-73. Nagarajan R, Iqbal Z, Burns B, Wilson NE, Sarma MK, Margolis DA, Reiter RE, Raman SS, Thomas MA. PMID: 26346702.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology. AJR Am J Roentgenol. 2015 Jul; 205(1):W87-92. Tan N, Margolis DJ, Lu DY, King KG, Huang J, Reiter RE, Raman SS. PMID: 26102423.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    45. A fully human scFv phage display library for rapid antibody fragment reformatting. Protein Eng Des Sel. 2015 Oct; 28(10):307-16. Li K, Zettlitz KA, Lipianskaya J, Zhou Y, Marks JD, Mallick P, Reiter RE, Wu AM. PMID: 25991864.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    46. Risk stratification of prostate cancer in the modern era. Curr Opin Urol. 2015 May; 25(3):246-51. Behesnilian AS, Reiter RE. PMID: 25730325.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    47. Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer. Clin Cancer Res. 2014 Dec 15; 20(24):6367-78. Knowles SM, Tavaré R, Zettlitz KA, Rochefort MM, Salazar FB, Jiang ZK, Reiter RE, Wu AM. PMID: 25326233.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    48. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol. 2015 Mar; 67(3):569-76. Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, Huang J, Margolis DJ, Raman SS, Reiter RE. PMID: 25257029.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    49. Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer. Urol Oncol. 2014 Oct; 32(7):952-7. Sonn GA, Filson CP, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. PMID: 25027689.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    50. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. J Urol. 2014 Nov; 192(5):1367-73. Le JD, Stephenson S, Brugger M, Lu DY, Lieu P, Sonn GA, Natarajan S, Dorey FJ, Huang J, Margolis DJ, Reiter RE, Marks LS. PMID: 24793118.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    51. Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody. J Nucl Med. 2014 Mar; 55(3):452-9. Knowles SM, Zettlitz KA, Tavaré R, Rochefort MM, Salazar FB, Stout DB, Yazaki PJ, Reiter RE, Wu AM. PMID: 24504052.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    52. The role of magnetic resonance imaging in delineating clinically significant prostate cancer. Urology. 2014 Feb; 83(2):369-75. Chamie K, Sonn GA, Finley DS, Tan N, Margolis DJ, Raman SS, Natarajan S, Huang J, Reiter RE. PMID: 24468511.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    53. Multidimensional MR spectroscopic imaging of prostate cancer in vivo. NMR Biomed. 2014 Jan; 27(1):53-66. Thomas MA, Nagarajan R, Huda A, Margolis D, Sarma MK, Sheng K, Reiter RE, Raman SS. PMID: 23904127.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines. Prostate. 2013 Sep; 73(13):1378-90. Seiler D, Zheng J, Liu G, Wang S, Yamashiro J, Reiter RE, Huang J, Zeng G. PMID: 23728788.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    55. MR Spectroscopic Imaging of Peripheral Zone in Prostate Cancer Using a 3T MRI Scanner: Endorectal versus External Phased Array Coils. Magn Reson Insights. 2013; 6:51-8. Nagarajan R, Margolis DJ, Raman SS, Ouellette D, Sarma MK, Reiter RE, Thomas MA. PMID: 25114544.
      View in: PubMed   Mentions:
    56. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 2014 Apr; 65(4):809-15. Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. PMID: 23523537.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    57. Radical prostatectomy: value of prostate MRI in surgical planning. Abdom Imaging. 2012 Aug; 37(4):664-74. Tan N, Margolis DJ, McClure TD, Thomas A, Finley DS, Reiter RE, Huang J, Raman SS. PMID: 21993567.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers. Urology. 2012 Jul; 80(1):219-23. Finley DS, Ellingson BM, Natarajan S, Zaw TM, Raman SS, Schulam P, Reiter RE, Margolis D. PMID: 22748877.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    59. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores. J Magn Reson Imaging. 2012 Sep; 36(3):697-703. Nagarajan R, Margolis D, Raman S, Sarma MK, Sheng K, King CR, Verma G, Sayre J, Reiter RE, Thomas MA. PMID: 22581787.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    60. Use of MR imaging to determine preservation of the neurovascular bundles at robotic-assisted laparoscopic prostatectomy. Radiology. 2012 Mar; 262(3):874-83. McClure TD, Margolis DJ, Reiter RE, Sayre JW, Thomas MA, Nagarajan R, Gulati M, Raman SS. PMID: 22274837.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    61. Fine-tuning robot-assisted radical prostatectomy planning with MRI. Urol Oncol. 2013 Aug; 31(6):766-75. Finley DS, Margolis D, Raman SS, Ellingson BM, Natarajan S, Tan N, Huang J, Reiter RE. PMID: 21906964.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med. 2010 Dec; 16(12):1414-20. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE. PMID: 21057494.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansAnimalsCells
    63. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate. 2010 Apr 01; 70(5):491-501. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON. PMID: 19938015.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    64. An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. Eur J Nucl Med Mol Imaging. 2010 Aug; 37(8):1529-38. Lepin EJ, Leyton JV, Zhou Y, Olafsen T, Salazar FB, McCabe KE, Hahm S, Marks JD, Reiter RE, Wu AM. PMID: 20354850.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    65. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst. 2009 Jun 16; 101(12):888-92. Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. PMID: 19509365.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansPHPublic Health
    66. Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors. Clin Cancer Res. 2008 Nov 15; 14(22):7488-96. Leyton JV, Olafsen T, Lepin EJ, Hahm S, Bauer KB, Reiter RE, Wu AM. PMID: 19010866.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    67. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors. Protein Eng Des Sel. 2009 Mar; 22(3):209-16. Leyton JV, Olafsen T, Sherman MA, Bauer KB, Aghajanian P, Reiter RE, Wu AM. PMID: 18957406.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    68. Androgen receptor and invasion in prostate cancer. Cancer Res. 2008 Feb 15; 68(4):1128-35. Hara T, Miyazaki H, Lee A, Tran CP, Reiter RE. PMID: 18281488.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    69. What factors affect the PSA relapse-free survival times in patients treated with permanent seed brachytherapy? Nat Clin Pract Urol. 2007 Dec; 4(12):650-1. Reiter RE, Riggs S. PMID: 17955047.
      View in: PubMed   Mentions:    Fields:    
    70. A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther. 2007 Nov; 15(11):1973-81. Pariente N, Morizono K, Virk MS, Petrigliano FA, Reiter RE, Lieberman JR, Chen IS. PMID: 17653099.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    71. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007 Jun 01; 109(11):2239-47. Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, Reiter RE. PMID: 17455209.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    72. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody. J Immunother. 2007 May-Jun; 30(4):396-405. Olafsen T, Gu Z, Sherman MA, Leyton JV, Witkosky ME, Shively JE, Raubitschek AA, Morrison SL, Wu AM, Reiter RE. PMID: 17457214.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    73. Improvements in prostate brachytherapy dosimetry due to seed stranding. Brachytherapy. 2007 Jan-Mar; 6(1):44-8. Lin K, Lee SP, Cho JS, Reiter RE, DeMarco JJ, Solberg TD. PMID: 17284385.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    74. An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer. Appl Immunohistochem Mol Morphol. 2006 Dec; 14(4):375-83. Rao DS, Gui D, Koski ME, Popoviciu LM, Wang H, Reiter RE, Said JW. PMID: 17122632.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    75. Stem cells in prostate and prostate cancer development. Urol Oncol. 2006 Mar-Apr; 24(2):131-40. Lam JS, Reiter RE. PMID: 16520277.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    76. What are the operating characteristics of PSA screening for prostate cancer? Nat Clin Pract Urol. 2006 Feb; 3(2):74-5. Reiter RE, Shurtleff B. PMID: 16470202.
      View in: PubMed   Mentions:    Fields:    
    77. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism. Cancer Res. 2005 Oct 15; 65(20):9495-500. Gu Z, Yamashiro J, Kono E, Reiter RE. PMID: 16230414.
      View in: PubMed   Mentions: 31     Fields:    Translation:Animals
    78. Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res. 2005 Apr 01; 11(7):2591-6. Lam JS, Yamashiro J, Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW, Reiter RE. PMID: 15814638.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    79. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res. 2005 Mar 15; 11(6):2237-43. Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, Brooks JD, Loda M, Reiter RE. PMID: 15788672.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    80. Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer. Clin Cancer Res. 2004 Dec 15; 10(24):8351-6. Thomas GV, Horvath S, Smith BL, Crosby K, Lebel LA, Schrage M, Said J, De Kernion J, Reiter RE, Sawyers CL. PMID: 15623612.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    81. Molecular markers and prostate cancer prognosis. Clin Prostate Cancer. 2004 Dec; 3(3):157-64. Chin JL, Reiter RE. PMID: 15636682.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    82. Genetic alterations in prostate cancer. Curr Urol Rep. 2004 Jun; 5(3):157-65. Chin JL, Reiter RE. PMID: 15161563.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol. 2004 Mar; 171(3):1117-21. Han KR, Seligson DB, Liu X, Horvath S, Shintaku PI, Thomas GV, Said JW, Reiter RE. PMID: 14767283.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    84. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens. J Urol. 2003 Jun; 169(6):2094-100. Cheng L, Reiter RE, Jin Y, Sharon H, Wieder J, Lane TF, Rao J. PMID: 12771726.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    85. Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression. Urology. 2003 Jun; 61(6):1187-92. Freedland SJ, de Gregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Elashoff DA, Reiter RE, Aronson WJ. PMID: 12809895.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    86. Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy. J Urol. 2003 Apr; 169(4):1325-30. Freedland SJ, deGregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Dorey F, Reiter RE, Aronson WJ. PMID: 12629353.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    87. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate. 2003 Apr 01; 55(1):9-19. Christiansen JJ, Rajasekaran SA, Moy P, Butch A, Goodglick L, Gu Z, Reiter RE, Bander NH, Rajasekaran AK. PMID: 12640656.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    88. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res. 2002 Dec; 1(2):113-21. Tran CP, Lin C, Yamashiro J, Reiter RE. PMID: 12496358.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    89. Monoclonal antibody therapy for genitourinary oncology: promise for the future. J Urol. 2002 Dec; 168(6):2615-23. Palapattu GS, Reiter RE. PMID: 12441996.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    90. Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol Endocrinol. 2002 Oct; 16(10):2323-37. Jain A, Lam A, Vivanco I, Carey MF, Reiter RE. PMID: 12351697.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    91. Role of prostate stem cell antigen in prostate cancer research. Curr Opin Urol. 2002 Sep; 12(5):401-6. Jalkut MW, Reiter RE. PMID: 12172427.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    92. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):401-6. Watabe T, Lin M, Ide H, Donjacour AA, Cunha GR, Witte ON, Reiter RE. PMID: 11752398.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    Robert's Networks
    Concepts (332)
    Derived automatically from this person's publications.
    _
    Co-Authors (48)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _